162 related articles for article (PubMed ID: 33476826)
1. NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies.
Ding Y; Ma Y; Du C; Wang C; Chen T; Wang Y; Wang J; Yao Y; Dong CM
Acta Biomater; 2021 Mar; 123():335-345. PubMed ID: 33476826
[TBL] [Abstract][Full Text] [Related]
2. NIR-Responsive Polypeptide Nanocomposite Generates NO Gas, Mild Photothermia, and Chemotherapy to Reverse Multidrug-Resistant Cancer.
Ding Y; Du C; Qian J; Dong CM
Nano Lett; 2019 Jul; 19(7):4362-4370. PubMed ID: 31199153
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
4. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-containing supramolecular polypeptide nanomedicine based on [2]biphenyl-extended-pillar[6]arenes for drug resistance reversal.
Ding Y; Ma Y; Zhu L; Xu Y; Wang C; Lu B; Wang Y; Du C; Yao Y
J Mater Chem B; 2022 Aug; 10(32):6181-6186. PubMed ID: 35894857
[TBL] [Abstract][Full Text] [Related]
6. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging-Guided Multi-Drug Chemotherapy and Photothermal Synergistic Therapy with pH and NIR-Stimulation Release.
Yang JC; Chen Y; Li YH; Yin XB
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22278-22288. PubMed ID: 28616966
[TBL] [Abstract][Full Text] [Related]
9. Glutathione detonated and pH responsive nano-clusters of Au nanorods with a high dose of DOX for treatment of multidrug resistant cancer.
Wang Y; Wang F; Liu Y; Xu S; Shen Y; Feng N; Guo S
Acta Biomater; 2018 Jul; 75():334-345. PubMed ID: 29885528
[TBL] [Abstract][Full Text] [Related]
10. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
[TBL] [Abstract][Full Text] [Related]
11. Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO
Li S; Song X; Zhu W; Chen Y; Zhu R; Wang L; Chen X; Song J; Yang H
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30066-30076. PubMed ID: 32393026
[TBL] [Abstract][Full Text] [Related]
12. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
[TBL] [Abstract][Full Text] [Related]
13. pH- and photothermal-driven multistage delivery nanoplatform for overcoming cancer drug resistance.
Huang W; Zhao H; Wan J; Zhou Y; Xu Q; Zhao Y; Yang X; Gan L
Theranostics; 2019; 9(13):3825-3839. PubMed ID: 31281516
[TBL] [Abstract][Full Text] [Related]
14. Subcellular-Targeted Near-Infrared-Responsive Nanomedicine with Synergistic Chemo-photothermal Therapy against Multidrug Resistant Cancer.
Tang Z; Tian W; Long H; Jiang S; Zhao J; Zhou J; He Q; Luo X
Mol Pharm; 2022 Dec; 19(12):4538-4551. PubMed ID: 35311257
[TBL] [Abstract][Full Text] [Related]
15. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
16. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
[TBL] [Abstract][Full Text] [Related]
17. A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer.
Jiang Y; Guo Z; Fang J; Wang B; Lin Z; Chen ZS; Chen Y; Zhang N; Yang X; Gao W
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110224. PubMed ID: 31761194
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R
Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609
[TBL] [Abstract][Full Text] [Related]
19. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
[TBL] [Abstract][Full Text] [Related]
20. A tumor targeted near-infrared light-controlled nanocomposite to combat with multidrug resistance of cancer.
Wang M; Wu J; Li Y; Li F; Hu X; Wang G; Han M; Ling D; Gao J
J Control Release; 2018 Oct; 288():34-44. PubMed ID: 30171977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
